House Passes ACA Healthcare Subsidies Extension
Passage of the bill in the Senate remains uncertain
Passage of the bill in the Senate remains uncertain
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Goal is to prepare University of California health centers for success in value-based care models by participating in alternative payment model contracts
Health system working with startup Atalan on development of a platform module designed to bridge clinician retention and patient experience data
British health standards exec succeeds Charles Jaffe, M.D., Ph.D., who led HL7 for nearly two decades
OpenAI says that with the additional context, ChatGPT Health could help users understand the tradeoffs of different insurance options based on their healthcare patterns
Ventyx Biosciences’ lead program, an oral small molecule inhibitor of NLRP3, has encouraging clinical data from separate mid-stage tests in cardiovascular disease and Parkinson’s disease. Eli Lilly said Ventyx’s pipeline has potential applications in cardiometabolic health, neurodegeneration, and autoimmunity. The post Eli Lilly Boosts Its Immunology Drug Pipeline With $1.2B Ventyx Bio Acquisition appeared first…
In his latest JAMA Forum column, KFF’s Larry Levitt explores how unaffordable health care is in the U.S. in the context of the debate over extending enhanced Affordable Care Act premium tax credits and an upcoming election where affordability will likely be front and center.
Those who act first will lower cost to serve, boost rep productivity and deliver customer experiences that feel personal, not programmatic. Those who wait risk falling behind as competitors turn engagement into a true differentiator. The post Pharma’s Make-or-Break Moment: How AI Is Rewriting the Rules of Customer Engagement appeared first on MedCity News.
While there is a significant need and opportunity to address this overall spend with advanced AI tools that predict patient needs and readmission likelihood, intrinsic biases within these algorithms ultimately cause more harm than good and financial savings are being achieved at the expense of patient’s health. The post AI Decides Who Gets Care: Tackling…